KCP Antibody - BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-81728
![Western Blot: KCP AntibodyBSA Free [NBP2-81728]](https://resources.bio-techne.com/images/products/KCP-Antibody-Western-Blot-NBP2-81728-img0001.jpg "Western Blot: KCP AntibodyBSA Free [NBP2-81728]")
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human, Mouse, Rat
Applications
ELISA, Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Format
BSA Free
Concentration
1 mg/ml
Product Specifications
Immunogen
KCP antibody was raised against a 15 amino acid synthetic peptide near the carboxy terminus of human KCP. The immunogen is located within amino acids 1320 - 1370 of KCP. Amino Acid Squence: RAAGYRARREANAR
Specificity
At least two isoforms of KCP are known to exist; this antibody will only detect the larger isoform. KCP antibody is predicted to not cross-react with CRIM1.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for KCP Antibody - BSA Free
Western Blot: KCP AntibodyBSA Free [NBP2-81728]
Western Blot: KCP Antibody [NBP2-81728] - Western blot analysis of KCP in Jurkat cell lysate with KCP antibody at (A) 1 and (B) 2 ug/mL.Applications for KCP Antibody - BSA Free
Application
Recommended Usage
Western Blot
1-2 ug/ml
Formulation, Preparation, and Storage
Purification
Peptide affinity purified
Formulation
PBS
Format
BSA Free
Preservative
0.02% Sodium Azide
Concentration
1 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: KCP
Alternate Names
CRIM2, KCP1, kielin/chordin-like protein, NET67
Gene Symbol
KCP
Additional KCP Products
Product Documents for KCP Antibody - BSA Free
Product Specific Notices for KCP Antibody - BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...